Clinical Potential of C-Reactive Protein and Procalcitonin Serum Concentrations To Guide Differential Diagnosis and Clinical Management of Pneumococcal and Legionella Pneumonia-Reference-Cited by-同舟云学术

Clinical Potential of C-Reactive Protein and Procalcitonin Serum Concentrations To Guide Differential Diagnosis and Clinical Management of Pneumococcal and Legionella Pneumonia

Published:2010-05 Issue:5 Volume:48 Page:1915-1917
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Bellmann-Weiler Rosa¹,Ausserwinkler Mathias¹,Kurz Katharina¹,Theurl Igor¹,Weiss Guenter¹

Affiliation:

1. Department of Internal Medicine I, Clinical Immunology and Infectious Diseases, Medical University of Innsbruck, Innsbruck, Austria

Abstract

ABSTRACT We retrospectively analyzed the records of 61 hospitalized patients with community-acquired pneumonia (CAP) caused by S treptococcus pneumoniae or L egionella pneumophila . We found that serum procalcitonin and sodium concentrations were significantly lower, and ferritin levels were significantly higher, in patients infected with L. pneumophila than in those infected with S. pneumoniae . The ratio of C-reactive protein to procalcitonin significantly distinguished between the groups. High procalcitonin levels were associated with an adverse clinical course.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01348-09

Reference20 articles.

1. Bartlett, J. G. 2008. Is activity against “atypical” pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin. Infect. Dis.47(Suppl. 3):S232-S236.

2. Christ-Crain, M., D. Stolz, R. Bingisser, C. Mueller, D. Miedinger, P. R. Huber, W. Zimmerli, S. Harbarth, M. Tamm, and B. Mueller. 2006. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med.174:84-93.

3. Cianciotto, N. P. 2007. Iron acquisition by Legionella pneumophila. Biometals20:323-331.

4. Performance of a Pneumolysin Enzyme-Linked Immunosorbent Assay for Diagnosis of Pneumococcal Infections

5. Diederen, B. M. 2008. Legionella spp. and Legionnaires' disease. J. Infect.56:1-12.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can the mucosal attacks of Behçet’s disease be predicted?;Archives of Dermatological Research;2024-01-18

2. Use of biomarkers to individualize antimicrobial therapy duration: a narrative review;Clinical Microbiology and Infection;2023-02

3. Procalcitonin As a Biomarker and Mediator of Sepsis: Implications for Critical Care;Biomarkers in Trauma, Injury and Critical Care;2023

4. Procalcitonin As a Biomarker and Mediator of Sepsis: Implications for Critical Care;Biomarkers in Trauma, Injury and Critical Care;2022

5. Clinical utility of procalcitonin and its association with pathogenic microorganisms;Critical Reviews in Clinical Laboratory Sciences;2021-10-18